Cannabix Technologies Begins Production of BreathLogix Devices

The latest update is out from Cannabix Technologies ( (TSE:BLO) ).

Cannabix Technologies has initiated the first production of its BreathLogix alcohol screening devices, partnering with Price Electronics for manufacturing. The BreathLogix Workplace Series device has been approved by the National Highway Traffic Safety Association for inclusion in the U.S. Federal Register Conforming Products List, and the company has secured an exclusive distribution agreement for Australia, New Zealand, and the Pacific Islands, potentially enhancing its market presence in these regions.

Spark’s Take on TSE:BLO Stock

According to Spark, TipRanks’ AI Analyst, TSE:BLO is a Underperform.

Cannabix Technologies has a low overall stock score due to severe financial challenges, characterized by zero revenue and ongoing losses. While technical indicators and recent corporate developments provide some optimism, the company’s speculative valuation and financial instability remain significant concerns.

To see Spark’s full report on TSE:BLO stock, click here.

More about Cannabix Technologies

Cannabix Technologies Inc. operates in the breath analysis industry, focusing on developing marijuana and alcohol breath devices. The company aims to provide innovative solutions for substance detection, with a market focus that includes workplace safety and law enforcement.

Average Trading Volume: 27,856

Technical Sentiment Signal: Buy

Current Market Cap: C$65.63M

See more data about BLO stock on TipRanks’ Stock Analysis page.